Detalhe da pesquisa
1.
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.
Ann Oncol
; 26(9): 1941-1947, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109631
2.
Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.
Biochem Pharmacol
; 61(7): 867-76, 2001 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11274973
3.
Reduced infections with perioperative immunonutrition in head and neck cancer: exploratory results of a multicenter, prospective, randomized, double-blind study.
Clin Nutr
; 33(5): 776-84, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24182765
4.
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.
Ann Oncol
; 12(10): 1439-43, 2001 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-11762817
5.
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.
Ann Oncol
; 7(1): 95-8, 1996 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-9081400